Recent News

• 12.12.2025 - 144 - Report of proposed sale of securities
• 11.12.2025 - Oragenics Q3 2025 Shareholder Update
• 11.12.2025 - 8-K - Current report
• 11.07.2025 - 10-Q - Quarterly report [Sections 13 or 15(d)]
• 10.21.2025 - Oragenics Regains Full NYSE American Compliance, Company Resolves Stockholder Equity Deficiency
• 10.21.2025 - 8-K - Current report
• 10.07.2025 - Oragenics Announces Strategic Partnership with Receptor.AI to Accelerate Pipeline Development
• 09.02.2025 - 8-K - Current report
• 09.02.2025 - 3 - Initial statement of beneficial ownership of securities
• 09.02.2025 - CORRESP - Correspondence

Recent Filings

• 11.12.2025 - EX-99.1 EX-99.1
• 11.12.2025 - 8-K Current report
• 11.07.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 10.21.2025 - EX-99.1 EX-99.1
• 10.21.2025 - 8-K Current report
• 09.02.2025 - 3 Initial statement of beneficial ownership of securities